BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20437461)

  • 1. Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion.
    Fan J; Maeng HJ; Pang KS
    Biopharm Drug Dispos; 2010 May; 31(4):215-27. PubMed ID: 20437461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
    Sun H; Pang KS
    Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis.
    Tam D; Sun H; Pang KS
    Drug Metab Dispos; 2003 Oct; 31(10):1214-26. PubMed ID: 12975330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: demonstration of substrate inhibition.
    Sun H; Zhang L; Chow EC; Lin G; Zuo Z; Pang KS
    J Pharmacol Exp Ther; 2008 Jul; 326(1):117-26. PubMed ID: 18385448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparity in intestine disposition between formed and preformed metabolites and implications: a theoretical study.
    Sun H; Pang KS
    Drug Metab Dispos; 2009 Jan; 37(1):187-202. PubMed ID: 18948379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the first-pass glucuronidation of selected flavones in gut by Caco-2 monolayer model.
    Ng SP; Wong KY; Zhang L; Zuo Z; Lin G
    J Pharm Pharm Sci; 2004 Dec; 8(1):1-9. PubMed ID: 15946592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net glutathione secretion across primary cultured rabbit conjunctival epithelial cell layers.
    Gukasyan HJ; Lee VH; Kim KJ; Kannan R
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1154-61. PubMed ID: 11923260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
    Yu L; Zeng S
    J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
    Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
    Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct mechanisms of zinc uptake at the apical and basolateral membranes of caco-2 cells.
    Raffaniello RD; Lee SY; Teichberg S; Wapnir RA
    J Cell Physiol; 1992 Aug; 152(2):356-61. PubMed ID: 1639868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulating kinetic parameters in transporter mediated permeability across Caco-2 cells. A case study of estrone-3-sulfate.
    Rolsted K; Rapin N; Steffansen B
    Eur J Pharm Sci; 2011 Oct; 44(3):218-26. PubMed ID: 21888970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
    Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
    Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxol transport by human intestinal epithelial Caco-2 cells.
    Walle UK; Walle T
    Drug Metab Dispos; 1998 Apr; 26(4):343-6. PubMed ID: 9531522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.
    Augustijns PF; Borchardt RT
    Drug Metab Dispos; 1995 Dec; 23(12):1372-8. PubMed ID: 8689946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of transporters and enzymes in hepatic drug processing.
    Liu L; Pang KS
    Drug Metab Dispos; 2005 Jan; 33(1):1-9. PubMed ID: 15466164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells.
    Burton PS; Conradi RA; Hilgers AR; Ho NF
    Biochem Biophys Res Commun; 1993 Feb; 190(3):760-6. PubMed ID: 8439326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.